AppSens is a Norwegian MedTech company having developed and introduced the innovative cardiac monitoring sensor system ECG247. ECG247 enables a user-friendly, efficient and affordable ECG procedure (electrocardiography) that detects atrial fibrillation and other arrhythmias that may prevent stroke or heart failure.
The ECG247 technology consists of advanced algorithms, back-end and cloud-based data processing and the use of AI.
ECG247 is currently in use in hospitals, heart specialist clinics, general practitioners in several countries. In Norway, it is also available in pharmacy online stores.